Articles
Industry Leader and Globally Recognized Patient Advocate John F. Crowley Appointed to Lead BIO as President & CEO
Biotech entrepreneur, company founder, tireless patient advocate, and U.S. Navy combat veteran will guide the life science industry in its mission to feed, fuel and heal the world December 5, 2023 | The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President…
Read MoreLarge Majority of Americans Say Consideration of Clinical Trial Participation Should be a Part of Regular Health Care
New National Public Opinion Survey Reveals Willingness to Participate in Clinical Trials; Importance of Trials Reflecting the Population; Concerns About Sharing Personal Health Information Have Grown Arlington, VA – December 5, 2023 – According to survey findings released today, an overwhelming majority of Americans (87%) agree that health care professionals should discuss clinical trials…
Read MoreMicron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles
November 16, 2023 November 16 2023, ATLANTA– Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, today announced a $23.6 million grant from the Bill & Melinda Gates Foundation that will fund mass production of needle-free vaccines. The manufacturing facility will…
Read MoreEchoing the Optimism for Medtech and Bioscience Venture Investment in the Southeast
In the final session of the 2023 Georgia Life Sciences Summit, four life science venture investors joined Radyus Research CEO Marta New to discuss best practices and errors to avoid for early stage life science companies building an “investment stack” along with their perceptions of the southeast life science innovation ecosystem and its “investability.” If…
Read MorePutting the Tech in Bio & MedTech
The convergence of life and data sciences promises to dramatically accelerate the pace of innovation and drug development. Georgia is emerging as a leader in combining these fields to address some of the most challenging problems in life sciences. While generative AI is not ready to support clinical decision making, “Intelligent call centers, appointment setting,…
Read MoreLife Science Nation bringing a medtech investor event to Atlanta in early 2024
In September, Life Science Nation announced “RESI South’ in partnership with a newly formed coalition of life science associations representing Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. The conference will come to Atlanta, GA, in [early] 2024. RESI South is expected to draw a crowd of over 500 bioscience and medtech entrepreneurs…
Read MoreJohns Creek Named First “BioReady Community” in Georgia
As the life sciences sector in Georgia continues to grow at a rapid pace, the need for bioready sites grows. As just the second state in the country to formally adopt such a program, the BioReady Community program will allow Georgia’s municipalities to showcase biotech-zoned science parks, streamline permitting, build a robust infrastructure, and identify…
Read MoreDr. Ted W. Love: How to reframe the narrative about biotech – and put patients first
November 2, 2023 / Source BIO News Remarks from Dr. Ted W. Love, Chairman of the Biotechnology Innovation Organization (BIO) and former President and CEO of Global Blood Therapeutics, as prepared for delivery Georgia Bio’s Life Sciences Summit on November 1, 2023: Almost ten years ago, when our college-aged daughter Alex lived at home, I had a…
Read MoreDriven by Industry Demand, Georgia Bio Reemerges, Rededicates
A New Start Founded in 1989, Georgia Bio has been the entity around which the bioscience and medtech industry in the state, including academia, connects and advocates for its needs. Though recently latent in the visual presence to which stakeholders are accustomed, Georgia Bio has maintained, if not increased, its advocacy for the life science…
Read MoreFDA OKs Sanguina’s at-home test for anemia
People with anemia can now monitor levels of their hemoglobin with a simple test taken in the comfort of their homes. AnemoCheck Home, made by GRA-backed startup Sanguina, this month became the first at-home hemoglobin test kit to receive clearance by the U.S. Food and Drug Administration. Available only by prescription, the test involves a…
Read More